This two-party dialogue exercise features a real-life dispute between Merck and Johnson & Johnson viewing European distribution rights to two highly profitable drugs.
RemicadeSimponi Confidential Instructions for Johnson & Johnson case study solution
PUBLICATION DATE: May 04, 2011 PRODUCT #: 911045-PDF-ENG
This is just an excerpt. This case is about COMMUNICATION
Related Case Solutions & Analyses:
Governance and Talent Management in a Professional Services Firm
The Bottom-line Benefits of Ethics Code Commitment
Lessons from Pharmaceutical Product Litigation: Merck and the Vioxx Withdrawal Cona & McDarby vs. Merck Video Supplement
ATH MicroTechnologies: Making the Numbers
Critical Competitive Strategy Issues Every Entrepreneur Should Consider Before Going into Business
Personal Selling and Sales Management
Reputation in Online Auctions: The Market for Trust
Black & Decker Corp.: Spacemaker Plus Coffeemaker (A)
The Sandbox: Creating a Bottom-Up Entrepreneurial Ecosystem
Retail Execution: Linens ‘N Things
